Work

Combination of CpG7909 and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL): A phase I, open label dose-escalation study of safety and tolerability

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.6594

Authors: G. J. Weiner, B. K. Link, J. Leonard, C. Emmanouilides, G. Albert, T. Schmalbach

Institutions: University of Iowa, Ronald Reagan UCLA Medical Center, UCLA Medical Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2256799441

Cites:

Cited by: 7

Related to: 10